Microstructure Formation and Characterization of Long-Acting Injectable Microspheres: The Gateway to Fully Controlled Drug Release Pattern
19 Feb 2024 07:39 GMT
… collapse after freeze-drying treatment. Freeze-dried products … non-destructive drug localization in exenatide microspheres.106
… Matrix. Front Bioeng Biotechnol. 2019;7:303. … comprehensive map of FDA-approved pharmaceutical products. Pharmaceutics. 2018;10:263 …
Molecular Pharmacology of Glucagon-Like Peptide 1-Based Therapies in the Management of Type Two Diabetes Mellitus and Obesity
05 Apr 2025 14:48 GMT
… Compared to BID exenatide, Exenatide LAR demonstrated a more significant … Drug Administration (FDA) in 2014 and by the European Medicines … -week phase 2 trial involving DM2 patients … effective in obesity treatment. Clinical trials have demonstrated that …